medigraphic.com
SPANISH

Acta Pediátrica de México

Órgano Oficial del Instituto Nacional de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 3

<< Back Next >>

Acta Pediatr Mex 2019; 40 (3)

A patient with esophageal achalasia and common variable immunodeficiency: A Case report and review of the literature

Avelar-Rodríguez D, Toro-Monjaraz EM, Peña VR, Yamazaki-Nakashimada MA, Ramírez-Mayans JA
Full text How to cite this article

Language: Spanish
References: 10
Page: 143-147
PDF size: 189.24 Kb.


Key words:

Esophageal achalasia, Esophageal peristalsis, Esophageal Sphincter, Deglutition Disorders, Immunodeficiency, Autoimmune.

ABSTRACT

Background: Esophageal achalasia is characterized by defective esophageal peristalsis and insufficient relaxation of the lower esophageal sphincter secondary to degeneration of the myenteric plexus. The exact pathophysiological mechanism through which the myenteric plexus is damaged is not fully understood, but increasing evidence suggests that autoimmunity may play a role. Patients with primary immunodeficiencies often develop autoimmunity, and recent studies have shown an increased prevalence of autoimmune diseases in patients with esophageal achalasia.
Clinical case: We present the case of an 18-year-old female with a history of common variable immunodeficiency and a high degree of autoimmunity (alopecia, vitiligo and autoimmune thyroiditis), who presented with rapidly progressive dysphagia, chest pain, and food regurgitation. A barium swallow and a high-resolution esophageal manometry were performed, and she was diagnosed with type III esophageal achalasia, the least common subtype (10%).
Conclusion: Patients with primary immunodeficiencies often develop autoimmunity and may be at increased risk of developing esophageal achalasia. Further research is warranted in order to elucidate the role of autoimmunity in esophageal achalasia.


REFERENCES

  1. Franklin AL. Childhood achalasia: A comprehensive review of disease, diagnosis and therapeutic management. World J Gastrointest Endosc [Internet]. 2014;6(4):105. http://www. wjgnet.com/1948-5190/full/v6/i4/105.htm

  2. Romero-Hernández F, et al. Autoimmune comorbidity in achalasia patients. J Gastroenterol Hepatol. 2018;33(1):203-8. https://doi.org/10.1111/jgh.13839

  3. Booy JD, et al. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis Esophagus. 2012;25(3):209-13. https://doi.org/10.1111/j.1442- 2050.2011.01249.x

  4. Furuzawa-Carballeda J, et al. Achalasia -An Autoimmune Inflammatory Disease: A Cross-Sectional Study. J Immunol Res. 2015;2015:1-18. http://www.hindawi.com/journals/ jir/2015/729217/

  5. Azizi G, et al. Approach to the Management of Autoimmunity in Primary Immunodeficiency. Scand J Immunol. 2017 Jan;85(1):13-29. https://doi.org/10.1111/sji.12506

  6. Schmidt RE, Grimbacher B, Witte T. Autoimmunity and primary immunodeficiency: Two sides of the same coin? Nat Rev Rheumatol [Internet]. 2018;14(1):7-18. http:// dx.doi.org/10.1038/nrrheum.2017.198

  7. Dosanjh A. Autoimmunity and Immunodeficiency. Ped Rev [Internet]. 2015;36(11):489-95. http://pedsinreview.aappublications.org/content/36/11/489%5Cnhttp://dx.doi. org/10.1542/pir.36-11-489

  8. Hamer PW, et al. Type III achalasia -a clinical description. Dis Esophagus. 2017;(30):1-6.

  9. Kahrilas PJ, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160-74.

  10. Boeckx sta ens GE, etal. Achalasia. Lancet. 2014;383(9911):83-93. https://doi.org/10.1016/S0140- 6736(13)60651-0




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Pediatr Mex. 2019;40